Replies to post #212763 on Innovation Pharmaceuticals Inc (IPIX)

[georgejjl]

Innovation Pharmaceuticals' Prurisol comparison to Celgene's Otezla



Since 55% of subjects taking 100 mg twice per day and strictly adhering to the protocol achieved “clear” (0) or “almost clear” (1) in IGA, and since 108 subjects will be taking at least 150 mg twice per day, what percentage of the subjects in the current Phase 2b trial will achieved “clear” (0) or “almost clear” (1) in IGA? 82%


(200 mg group)

At Week 12: 42.8% subjects (ITT) [and 55.0% subjects (PP)] achieved “clear” (0) or “almost clear” (1) in IGA


https://static1.squarespace.com/static/5715352e20c647639137f992/t/5865318920099e2bc425d577/1483026833173/Cellceutix_Corporate_Slide+Deck_DERMATOLOGY_November+2016+Website+Vers.pdf

Good luck and GOD bless,

George